| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adherence to lumacaftor-ivacaftor therapy in patients with cystic fibrosis in France
|
Olivereau, Lucie
|
|
|
19 |
3 |
p. 402-406
|
artikel
|
| 2 |
A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis
|
Cosgriff, Rebecca
|
|
|
19 |
3 |
p. 355-358
|
artikel
|
| 3 |
Antimicrobial resistance in cystic fibrosis: A Delphi approach to defining best practices
|
Zemanick, Edith
|
|
|
19 |
3 |
p. 370-375
|
artikel
|
| 4 |
Asymptomatic case of Covid-19 in an infant with cystic fibrosis
|
Poli, Piercarlo
|
|
|
19 |
3 |
p. e18
|
artikel
|
| 5 |
CFTR-deficient pigs display alterations of bone microarchitecture and composition at birth
|
Braux, Julien
|
|
|
19 |
3 |
p. 466-475
|
artikel
|
| 6 |
Changes in the parent cystic fibrosis questionnaire-revised (CFQ-R) with respiratory symptoms in preschool children with cystic fibrosis
|
Perrem, Lucy
|
|
|
19 |
3 |
p. 492-498
|
artikel
|
| 7 |
Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis–data from the European cystic fibrosis society patient registry
|
Hatziagorou, Elpis
|
|
|
19 |
3 |
p. 376-383
|
artikel
|
| 8 |
Characterising burden of treatment in cystic fibrosis to identify priority areas for clinical trials
|
Davies, Gwyneth
|
|
|
19 |
3 |
p. 499-502
|
artikel
|
| 9 |
COVID-19 in lung-transplanted and cystic fibrosis patients: Be careful
|
Farfour, Eric
|
|
|
19 |
3 |
p. e16-e17
|
artikel
|
| 10 |
Cystic Fibrosis Foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease
|
Kapnadak, Siddhartha G.
|
|
|
19 |
3 |
p. 344-354
|
artikel
|
| 11 |
Editorial Board
|
|
|
|
19 |
3 |
p. ii
|
artikel
|
| 12 |
Evaluation of the exercise intensity generated by active video gaming in patients with cystic fibrosis and healthy individuals
|
Campos, Natália Evangelista
|
|
|
19 |
3 |
p. 434-441
|
artikel
|
| 13 |
First case of cystic fibrosis in Greenland – diagnosed by neonatal screening
|
M, Skov
|
|
|
19 |
3 |
p. e14-e15
|
artikel
|
| 14 |
Glucose ingestion in cystic fibrosis induces severe redox imbalance: A potential role in diabetes
|
Hunt, William R.
|
|
|
19 |
3 |
p. 476-482
|
artikel
|
| 15 |
Glycemic control and FEV1 recovery during pulmonary exacerbations in pediatric cystic fibrosis-related diabetes
|
Okoniewski, William
|
|
|
19 |
3 |
p. 460-465
|
artikel
|
| 16 |
Health-related quality-of-life in children with cystic fibrosis aged 5-years and associations with health outcomes
|
Cheney, Joyce
|
|
|
19 |
3 |
p. 483-491
|
artikel
|
| 17 |
Infection prevention and control in patients with cystic fibrosis (CF): Results from a survey in 35 German CF treatment centers
|
Meyer, Sonja
|
|
|
19 |
3 |
p. 384-387
|
artikel
|
| 18 |
Isolation of Enterobacteriaceae in airway samples is associated with worse outcome in preschool children with cystic fibrosis
|
Vermeulen, Francois
|
|
|
19 |
3 |
p. 365-369
|
artikel
|
| 19 |
Letter to the editor of JCF
|
Amaral, Margarida D.
|
|
|
19 |
3 |
p. 503
|
artikel
|
| 20 |
Lumacaftor/ivacaftor reduces exacerbations in adults homozygous for Phe508del mutation with severe lung disease
|
Tong, Koliarne
|
|
|
19 |
3 |
p. 415-420
|
artikel
|
| 21 |
News Article
|
|
|
|
19 |
3 |
p. 342-343
|
artikel
|
| 22 |
Occurrence, outcomes and predictors of portal hypertension in cystic fibrosis: A longitudinal prospective birth cohort study
|
Cipolli, Marco
|
|
|
19 |
3 |
p. 455-459
|
artikel
|
| 23 |
Overlooking the landscape of palliative care in cystic fibrosis
|
Chin, M.
|
|
|
19 |
3 |
p. 336-338
|
artikel
|
| 24 |
Pharmacokinetics of colistin after nebulization or intravenous administration of colistin methanesulphonate (Colimycin®) to cystic fibrosis patients
|
Magréault, Sophie
|
|
|
19 |
3 |
p. 421-426
|
artikel
|
| 25 |
Predictors of pulmonary exacerbation treatment in cystic fibrosis
|
Sanders, Don B.
|
|
|
19 |
3 |
p. 407-414
|
artikel
|
| 26 |
Prevalence of unmet palliative care needs in adults with cystic fibrosis
|
Trandel, Elizabeth T.
|
|
|
19 |
3 |
p. 394-401
|
artikel
|
| 27 |
Real-world evidence in cystic fibrosis modulator development: Establishing a path forward
|
Magaret, Amalia
|
|
|
19 |
3 |
p. e11-e12
|
artikel
|
| 28 |
Seven P's of publication practices
|
Bell, Scott C
|
|
|
19 |
3 |
p. 333-335
|
artikel
|
| 29 |
Structured surveillance of Achromobacter, Pandoraea and Ralstonia species from patients in England with cystic fibrosis
|
Coward, Amy
|
|
|
19 |
3 |
p. 388-393
|
artikel
|
| 30 |
Supersonic shear-wave elastography and APRI for the detection and staging of liver disease in pediatric cystic fibrosis
|
Calvopina, Diego A.
|
|
|
19 |
3 |
p. 449-454
|
artikel
|
| 31 |
Test-retest reliability, minimal detectable change and minimal clinically important differences in modified shuttle walk test in children and adolescents with cystic fibrosis
|
del Corral, Tamara
|
|
|
19 |
3 |
p. 442-448
|
artikel
|
| 32 |
The Emergence of Elastography for Cystic Fibrosis Liver Disease
|
Masand, P.M.
|
|
|
19 |
3 |
p. 339-341
|
artikel
|
| 33 |
The impact of CFTR modulator therapies on CF airway microbiology
|
Rogers, Geraint B.
|
|
|
19 |
3 |
p. 359-364
|
artikel
|
| 34 |
The implications of dysglycaemia on aerobic exercise and ventilatory function in cystic fibrosis
|
Causer, Adam J.
|
|
|
19 |
3 |
p. 427-433
|
artikel
|
| 35 |
Transparency and open access in CF research
|
Stanojevic, Sanja
|
|
|
19 |
3 |
p. e13
|
artikel
|
Tijdschrift beschrijving